Clinical Activities. For each R&D Project, Clinical activities-related costs shall be borne as follows: 4.4.2.1. All expenses (internal and external costs) incurred by the Parties in the performance of R&D Project clinical activities shall be exclusively borne by GenSight; 4.4.2.2. GenSight shall bear all costs (internal and external) for the manufacture of all GMP batches of Product other than any GMP preclinical toxicology batch(es), and the initial GMP batch for Phase 1 studies manufactured by Genethon, at Genethon’s costs, as contemplated above. The Parties shall negotiate diligently and in good faith a specific contract, under commercially reasonable terms, to cover the manufacture of these GMP batches of Product which shall, among other things, specify the price thereof.
Appears in 4 contracts
Samples: Partnership Agreement, Partnership Agreement (Gensight Biologics S.A.), Partnership Agreement (Gensight Biologics)
